drugset
drugset / Trial / NCT00385190

Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men

NCT00385190 ↗

Phase 1 Completed 24 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of the study is to assess the safety and tolerability of ascending multiple oral doses of HCV-796 in healthy Japanese male subjects.

Timeline

Start
2006-07
Primary completion
2006-11
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject NESBUVIR Small molecule — Oral

Indications

No indication recorded.